Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

In this quasi-experimental study conducted at a hypnosis clinic in Santiago de Cuba, therapeutic hypnosis was reported to reduce the severity of alopecia areata by up to 8.7% and completely eradicate symptoms in pediatric patients.

This study found evidence for a genetic basis of polycystic ovary syndrome, indicating an autosomal dominant pattern of inheritance among first-degree relatives.

This study found that pediatric alopecia areata patients had significantly lower serum BDNF levels compared to healthy controls, which were associated with greater alopecia severity, higher depressive symptoms, and poorer quality of life.

This study observed that pediatric patients with diffuse, non-scarring alopecia had significantly lower levels of zinc and folate compared to matched healthy controls, suggesting a possible link between these deficiencies and hair loss in children.

This case study reports the successful use of abrocitinib for treating severe alopecia areata in a 14-year-old patient, demonstrating significant hair regrowth and suggesting the need for sustained JAK1 inhibition to prevent relapse.

This study reported that six out of seven pediatric patients with refractory patchy alopecia areata experienced significant hair regrowth after one month of oral tofacitinib treatment, suggesting it may be an effective and safe option, although larger studies are needed to evaluate long-term safety.

This case study reported promising hair regrowth in a child with morphea en coup de sabre using fractional CO2 laser-assisted exosome therapy, but further research is needed to validate these findings due to its single-subject design.

This case study reported on a 6-year-old boy with Kindler Syndrome born to consanguineous parents, featuring atypical symptoms like hyperpigmented macules and glucose intolerance, contributing to expanding insights into the condition's phenotypic diversity.

In this case report, an 8-year-old girl with burn-induced cicatricial alopecia showed improved graft survival after hair transplantation due to preparatory microfat grafting, which enhanced tissue conditions and possibly increased follicular unit survival rates to about 80%, higher than typically expected.

In this narrative review, the authors concluded that while high-quality evidence for systemic therapies in pediatric alopecia areata is scarce, Janus kinase inhibitors have the most systematic support, with oral minoxidil and dupilumab also reported as potentially beneficial in certain cases.

This case report describes a child with alopecia areata and atopic dermatitis who showed significant improvement after treatment with baricitinib and corticosteroid ointment, suggesting their potential efficacy and safety.

In this case report, a 14-year-old male with alopecia areata subtotalis and nail involvement showed significant improvement after 9 months of treatment with oral tofacitinib, including complete hair regrowth and nail texture improvement, though further studies are needed to confirm these findings.

In this study, 55 pediatric patients with hidradenitis suppurativa were assessed, revealing common comorbidities like obesity and acne, a frequent delay in diagnosis, and that most patients experienced symptom improvement with treatment including antibiotics and hormone therapy.

In this study, xerosis and pruritus were common skin issues in pediatric chronic kidney disease patients, with xerosis linked to lower hemodialysis efficacy and higher white blood cells, and pruritis associated with higher hemoglobin levels.

This case report details the first use of baricitinib in a pediatric patient with immune thrombocytopenia and alopecia areata, showing successful treatment with increased platelet counts.

The conference highlighted new treatments and research in pediatric skin conditions, emphasizing collaboration and innovation.

This study reviewed phototherapy data for pediatric patients over 5 years, finding psoriasis as the most common condition treated. The researchers reported a lower incidence of side effects compared to similar studies but also noted lower treatment response rates.

In this case study, a 12-month-old girl presenting with apyretic seizure and congenital alopecia was diagnosed with hereditary vitamin D-resistant rickets, highlighting the importance of comprehensive evaluation for accurate diagnosis.

In this study, pediatric patients with alopecia areata treated with systemic tofacitinib showed significant improvement at 12 months, but the small sample size and retrospective design limit conclusions about its effectiveness.

In this study of pediatric melanocytic lesions, researchers at Massachusetts General Hospital observed no concurrent BAP1 loss and BRAFV600E positivity, characteristics of adult BIMT, suggesting that these tumors may develop at a later age rather than in childhood.

This study identified three clusters of autoantibodies in children with systemic lupus erythematosus, each associated with specific clinical manifestations at diagnosis.

In this study, 27 pediatric patients with alopecia areata treated with methotrexate showed statistically significant improvement in hair regrowth between 12-15 months, suggesting the medication's delayed but effective results, though common side effects included mood changes and gastrointestinal discomfort.

This study reports that pediatric alopecia areata in Faisalabad predominantly affects boys, often involves the scalp, and is significantly associated with family history of psoriasis and atopic disorders.

This review covers the dermatological manifestations linked to Covid-19 and personal protective equipment, noting the importance of skin barrier protection but provides no new clinical findings.

This study identified tinea capitis as the most common cause of alopecia in children, with a higher prevalence in boys than girls.

This overview describes the Dermatologic Surgery journal, which publishes extensive peer-reviewed content on skin surgery, but presents no new research findings.

This study found that pediatric traumatic brain injuries in Greater Vancouver were more common in areas with lower socioeconomic status, with significant associations between injury rates and lower educational attainment.

There's a growing resistance to the antibiotic mupirocin in children's skin infections caused by MRSA in New York.